drugset / Trial / NCT01480232
A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence
Phase 2
Terminated
345 enrolled
A. Eden Evins
FORUM Pharmaceuticals Inc · collabNational Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to evaluate the initial evidence for efficacy of the investigational medicine, EVP-6124, to improve smoking cessation outcomes with and without a standard taper of nicotine replacement therapy (NRT) in healthy nicotine dependent smokers
Timeline
- Start
- 2011-12
- Primary completion
- 2015-09
- Completion
- 2015-09
Outcome
Outcome not reported
Stopped: “Study has been put on clinical hold by FDA”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENCENICLINE | Small molecule | — | Oral |
| Subject | Nicoderm | Unknown | — | Other |